{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T13:11:32Z","timestamp":1791465092327,"version":"4.3.4"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"S7","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Bioinformatics"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1186\/s12859-019-2737-1","type":"journal-article","created":{"date-parts":[[2019,4,30]],"date-time":"2019-04-30T20:03:08Z","timestamp":1556654588000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Multiscale modeling reveals angiogenesis-induced drug resistance in brain tumors and predicts a synergistic drug combination targeting EGFR and VEGFR pathways"],"prefix":"10.1186","volume":"20","author":[{"given":"Weishan","family":"Liang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongjiang","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqiang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,5,1]]},"reference":[{"issue":"4","key":"2737_CR1","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/S1470-2045(11)70335-7","volume":"13","author":"NC Turner","year":"2012","unstructured":"Turner NC, Reis-Filho JS. Genetic heterogeneity and cancer drug resistance. Lancet Oncol. 2012;13(4):178\u201385.","journal-title":"Lancet Oncol"},{"issue":"5","key":"2737_CR2","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1016\/j.molcel.2014.05.015","volume":"54","author":"H Easwaran","year":"2014","unstructured":"Easwaran H, Tsai HC, Baylin SB. Cancer epigenetics: tumor heterogeneity, plasticity of stem-like states, and drug resistance. Mol Cell. 2014;54(5):716\u201327.","journal-title":"Mol Cell"},{"key":"2737_CR3","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1007\/978-3-319-48683-3_22","volume-title":"Drug Resistance in Bacteria, Fungi, Malaria, and Cancer","author":"S Aggarwal","year":"2017","unstructured":"Aggarwal S, Kandpal M, Asthana S, Yadav AK. Perturbed Signaling and Role of Posttranslational Modifications in Cancer Drug Resistance. In: Arora G, Sajid A, Kalia V. (eds). Drug Resistance in Bacteria, Fungi, Malaria, and Cancer. Cham: Springer; 2017. p. 483\u2013510."},{"issue":"3","key":"2737_CR4","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.ccell.2017.02.009","volume":"31","author":"DF Quail","year":"2017","unstructured":"Quail DF, Joyce JA. The microenvironmental landscape of brain tumors. Cancer Cell. 2017;31(3):326.","journal-title":"Cancer Cell"},{"issue":"2","key":"2737_CR5","first-page":"1","volume":"20","author":"M Bani","year":"2017","unstructured":"Bani M, Decio A, Giavazzi R, Ghilardi C. Contribution of tumor endothelial cells to drug resistance: anti-angiogenic tyrosine kinase inhibitors act as p-glycoprotein antagonists. Angiogenesis. 2017;20(2):1\u20139.","journal-title":"Angiogenesis"},{"issue":"9","key":"2737_CR6","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1016\/0277-5379(87)90133-7","volume":"23","author":"BG Birkhead","year":"1987","unstructured":"Birkhead BG, Rankin EM, Gallivan S, Dones L, Rubens RD. A mathematical model of the development of drug resistant to cancer chemotherapy. Eur J Cancer Clin Oncol. 1987;23(9):1421\u20137.","journal-title":"Eur J Cancer Clin Oncol"},{"issue":"2","key":"2737_CR7","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/0895-7177(95)00112-F","volume":"22","author":"JC Panetta","year":"1995","unstructured":"Panetta JC, Adam J. A mathematical model of cycle-specific chemotherapy. Math Comput Model Int J. 1995;22(2):67\u201382.","journal-title":"Math Comput Model Int J"},{"issue":"4","key":"2737_CR8","doi-asserted-by":"publisher","first-page":"905","DOI":"10.3934\/mbe.2010.7.905","volume":"7","author":"C Tomasetti","year":"2010","unstructured":"Tomasetti C, Levy D. An elementary approach to modeling drug resistance in cancer. Math Biosci Eng. 2010;7(4):905\u201318.","journal-title":"Math Biosci Eng"},{"issue":"3","key":"2737_CR9","doi-asserted-by":"publisher","first-page":"261","DOI":"10.2174\/138161206775201956","volume":"12","author":"F Michor","year":"2006","unstructured":"Michor F, Nowak MA, Iwasa Y. Evolution of resistance to cancer therapy. Curr Pharm Des. 2006;12(3):261\u201371.","journal-title":"Curr Pharm Des"},{"issue":"34","key":"2737_CR10","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.jtbi.2014.02.025","volume":"355","author":"J Foo","year":"2014","unstructured":"Foo J, Michor F. Evolution of acquired resistance to anti-cancer therapy. J Theor Biol. 2014;355(34):10\u201320.","journal-title":"J Theor Biol"},{"issue":"2","key":"2737_CR11","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.jtbi.2009.11.022","volume":"263","author":"J Foo","year":"2010","unstructured":"Foo J, Michor F. Evolution of resistance to anti-cancer therapy during general dosing schedules. J Theor Biol. 2010;263(2):179.","journal-title":"J Theor Biol"},{"issue":"1\u20132","key":"2737_CR12","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.cell.2011.11.060","volume":"148","author":"H Haeno","year":"2012","unstructured":"Haeno H, Gonen M, Davis MB, Herman JM, Iacobuziodonahue CA, Michor F. Computational modeling of pancreatic cancer reveals kinetics of metastasis suggesting optimum treatment strategies. Cell. 2012;148(1\u20132):362.","journal-title":"Cell"},{"key":"2737_CR13","doi-asserted-by":"publisher","first-page":"22498","DOI":"10.1038\/srep22498","volume":"6","author":"X Sun","year":"2016","unstructured":"Sun X, Bao J, Shao Y. Mathematical modeling of therapy-induced Cancer drug resistance: connecting Cancer mechanisms to population survival rates. Sci Rep. 2016;6:22498.","journal-title":"Sci Rep"},{"issue":"4","key":"2737_CR14","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1158\/1535-7163.MCT-17-0634","volume":"17","author":"Y Zheng","year":"2018","unstructured":"Zheng Y, Bao J, Zhao Q, Zhou T, Sun X. A Spatio-temporal model of macrophage-mediated drug resistance in glioma immunotherapy. Mol Cancer Ther. 2018;17(4):814\u201324.","journal-title":"Mol Cancer Ther"},{"issue":"11","key":"2737_CR15","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1002\/psp4.12018","volume":"4","author":"J Cosgrove","year":"2015","unstructured":"Cosgrove J, Butler J, Alden K, Read M, Kumar V, Cucurull-Sanchez L, Timmis J, Coles M. Agent-based modeling in systems pharmacology. CPT Pharmacometrics Syst Pharmacol. 2015;4(11):615\u201329.","journal-title":"CPT Pharmacometrics Syst Pharmacol"},{"issue":"2","key":"2737_CR16","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/s10928-015-9403-7","volume":"42","author":"Z Wang","year":"2015","unstructured":"Wang Z, Butner JD, Cristini V, Deisboeck TS. Integrated PK-PD and agent-based modeling in oncology. J Pharmacokinet Pharmacodyn. 2015;42(2):179\u201389.","journal-title":"J Pharmacokinet Pharmacodyn"},{"issue":"1","key":"2737_CR17","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1186\/1471-2105-13-218","volume":"13","author":"X Sun","year":"2012","unstructured":"Sun X, Zhang L, Tan H, Bao J, Strouthos C, Zhou X. Multi-scale agent-based brain cancer modeling and prediction of TKI treatment response: incorporating EGFR signaling pathway and angiogenesis. BMC bioinformatics. 2012;13(1):218.","journal-title":"BMC bioinformatics"},{"key":"2737_CR18","first-page":"444","volume-title":"Lecture Notes in Computer Science","author":"B. Ribba","year":"2004","unstructured":"Ribba B, Alarc\u00f3n T, Marron K, Maini PK, Agur Z. The use of hybrid cellular automaton models for improving cancer therapy. In: Cellular Automata. Berlin: Springer; 2004. p. 444\u201353."},{"issue":"7","key":"2737_CR19","doi-asserted-by":"publisher","first-page":"e0132306","DOI":"10.1371\/journal.pone.0132306","volume":"10","author":"\u00c1 Monteagudo","year":"2015","unstructured":"Monteagudo \u00c1, Santos J. Treatment analysis in a Cancer stem cell context using a tumor growth model based on cellular automata. PLoS One. 2015;10(7):e0132306.","journal-title":"PLoS One"},{"issue":"8","key":"2737_CR20","doi-asserted-by":"publisher","first-page":"2826","DOI":"10.1158\/0008-5472.CAN-10-2834","volume":"71","author":"MR Owen","year":"2011","unstructured":"Owen MR, Stamper IJ, Muthana M, Richardson GW, Dobson J, Lewis CE, Byrne HM. Mathematical modeling predicts synergistic antitumor effects of combining a macrophage-based, hypoxia-targeted gene therapy with chemotherapy. Cancer Res. 2011;71(8):2826\u201337.","journal-title":"Cancer Res"},{"issue":"02","key":"2737_CR21","doi-asserted-by":"publisher","first-page":"1550005","DOI":"10.1142\/S1793048015500058","volume":"10","author":"MAJ Chaplain","year":"2015","unstructured":"Chaplain MAJ, Powathil GG. Multiscale modelling of Cancer progression and treatment control: the role of intracellular heterogeneities in chemotherapy treatment. Biophys Rev Lett. 2015;10(02):1550005.","journal-title":"Biophys Rev Lett"},{"issue":"1","key":"2737_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2105-13-1","volume":"13","author":"X Sun","year":"2012","unstructured":"Sun X, Le Z, Hua T, Bao J, Strouthos C, Zhou X. Multi-scale agent-based brain cancer modeling and prediction of TKI treatment response: incorporating EGFR signaling pathway and angiogenesis. BMC Bioinformatics. 2012;13(1):1\u201314.","journal-title":"BMC Bioinformatics"},{"issue":"112","key":"2737_CR23","doi-asserted-by":"crossref","first-page":"re21","DOI":"10.1126\/stke.2001.112.re21","volume":"2001","author":"T Matsumoto","year":"2001","unstructured":"Matsumoto T, Claesson-Welsh L. VEGF receptor signal transduction. Sci STKE. 2001;2001(112):re21.","journal-title":"Sci STKE"},{"issue":"4","key":"2737_CR24","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1158\/1078-0432.CCR-06-1989","volume":"13","author":"BI Rini","year":"2007","unstructured":"Rini BI. Vascular endothelial growth factor\u2013targeted therapy in renal cell carcinoma: current status and future directions. Clin Cancer Res. 2007;13(4):1098\u2013106.","journal-title":"Clin Cancer Res"},{"issue":"7","key":"2737_CR25","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.1158\/1078-0432.CCR-05-1682","volume":"12","author":"JR Tonra","year":"2006","unstructured":"Tonra JR, Deevi DS, Corcoran E, Li H, Wang S, Carrick FE, Hicklin DJ. Synergistic Antitumor Effects of Combined Epidermal Growth Factor Receptor and Vascular Endothelial Growth Factor Receptor-2 Targeted Therapy. Clin Cancer Res. 2006;12(7):2197\u2013207.","journal-title":"Clin Cancer Res"},{"issue":"13","key":"2737_CR26","first-page":"3352","volume":"54","author":"Y Fan","year":"1994","unstructured":"Fan Y, Leunig M, Shi KH, Berk DA, Papahadjopoulos D, Jain RKJCR: Mirovascular Permeability and Interstitial Penetration of Sterically Stabilized (Stealth) Liposomes in a Human Tumor Xenograft. Cancer Res. 1994;54(13):3352\u201356.","journal-title":"Cancer Res"},{"issue":"10","key":"2737_CR27","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1038\/nrc1456","volume":"4","author":"CH Heldin","year":"2004","unstructured":"Heldin CH, Rubin K, Pietras K, Ostman A. High interstitial fluid pressure - an obstacle in cancer therapy. Nat Rev Cancer. 2004;4(10):806\u201313.","journal-title":"Nat Rev Cancer"},{"issue":"5","key":"2737_CR28","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1021\/bi00379a035","volume":"26","author":"Y Yarden","year":"1987","unstructured":"Yarden Y, Schlessinger J. Epidermal growth factor induces rapid, reversible aggregation of the purified epidermal growth factor receptor. Biochemistry. 1987;26(5):1443\u201351.","journal-title":"Biochemistry"},{"issue":"4","key":"2737_CR29","doi-asserted-by":"publisher","first-page":"R185","DOI":"10.1530\/ERC-15-0555","volume":"23","author":"D Viola","year":"2016","unstructured":"Viola D, Valerio L, Molinaro E, Agate L, Bottici V, Biagini A, Lorusso L, Cappagli V, Pieruzzi L, Giani C. Treatment of advanced thyroid cancer with targeted therapies: ten years of experience. Endocr Relat Cancer. 2016;23(4):R185.","journal-title":"Endocr Relat Cancer"},{"issue":"3","key":"2737_CR30","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1111\/j.1744-7348.1939.tb06990.x","volume":"26","author":"C Bliss","year":"1939","unstructured":"Bliss C. The toxicity of posons applied jointly. Ann Appl Biol. 1939;26(3):585\u2013615.","journal-title":"Ann Appl Biol"},{"issue":"9","key":"2737_CR31","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1038\/nchembio817","volume":"2","author":"JB Fitzgerald","year":"2006","unstructured":"Fitzgerald JB, Schoeberl B, Nielsen UB, Sorger PK. Systems biology and combination therapy in the quest for clinical efficacy. Nat Chem Biol. 2006;2(9):458\u201366.","journal-title":"Nat Chem Biol"},{"issue":"2","key":"2737_CR32","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","volume":"34","author":"D Cox","year":"1972","unstructured":"Cox D. Regression models and life tables. J Roy Stat Soc B. 1972;34(2):187\u2013220.","journal-title":"J Roy Stat Soc B"},{"issue":"2","key":"2737_CR33","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1111\/j.0006-341X.2000.00337.x","volume":"56","author":"PJ Heagerty","year":"2015","unstructured":"Heagerty PJ, Lumley T, Pepe MS. Time-dependent ROC curves for censored survival data and a diagnostic marker. Biometrics. 2015;56(2):337\u201344.","journal-title":"Biometrics"}],"container-title":["BMC Bioinformatics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12859-019-2737-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12859-019-2737-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12859-019-2737-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,17]],"date-time":"2024-07-17T09:56:01Z","timestamp":1721210161000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcbioinformatics.biomedcentral.com\/articles\/10.1186\/s12859-019-2737-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":33,"journal-issue":{"issue":"S7","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["2737"],"URL":"https:\/\/doi.org\/10.1186\/s12859-019-2737-1","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/394668","asserted-by":"object"}]},"ISSN":["1471-2105"],"issn-type":[{"value":"1471-2105","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"1 May 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"203"}}